Brief: Entera Bio-Entered Into Sales Agreement With SVB Securities LLC, Relating To Issuance, Sale, From Time To Time, Of Up To 5 Million Of Co’s Ordinary Shares
02/09/2022 21:15
Sept 2 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO-ENTERED INTO SALES AGREEMENT WITH SVB
SECURITIES LLC,
RELATING TO ISSUANCE, SALE, FROM TIME TO TIME, OF UP TO 5
MILLION OF CO’S ORDINARY SHARES
Further company coverage: 5DT.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement